Shahi Pharma India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 17.78%
- Profit Growth 74.08%
- Ebitda 504.13%
- Net Worth -3.81%
- Total Assets 86.11%
About Shahi Pharma India
Shahi Pharma India Private Limited (SPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 August 2018 (Six years and six months 9 days old ). Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Jewelry & Fashion Accessories Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Javed Ali and Salma Khatoon serve as directors at the Company.
Company Details
-
Location
Haridwar, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33309UR2018PTC008934
-
Company No.
008934
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Aug 2018
-
Date of AGM
29 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
What products or services does Shahi Pharma India Private Limited offer?
Shahi Pharma India Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Pain Balm & Ointments, Juices, Soups & Soft Drinks, Vegetable Juices, Ayurvedic Immunity Booster, Ayurvedic Medicine, Cardiovascular Drugs & Medication, Cardiac Drugs, Essential & Aromatic Oils, Spice Oil.
Who are the key members and board of directors at Shahi Pharma India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Javed Ali
|
Director | 10-Aug-2018 | Current |
|
Salma Khatoon
|
Director | 10-Aug-2018 | Current |
Financial Performance of Shahi Pharma India.
Shahi Pharma India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.78% increase. The company also saw a substantial improvement in profitability, with a 74.08% increase in profit. The company's net worth dipped by a decrease of 3.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shahi Pharma India?
Unlock access to Shahi Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Withania Pharmaceuticals Private LimitedJaved Ali and Salma Khatoon are mutual person
-
Shahi Laboratories Private Limited
Javed Ali and Salma Khatoon are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shahi Pharma India?
Unlock and access historical data on people associated with Shahi Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shahi Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shahi Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.